HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abbas Agaimy Selected Research

Salivary Gland Neoplasms (Salivary Gland Cancer)

5/2022High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases.
1/2022Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer.
10/2019NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
5/2013The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
6/2012EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abbas Agaimy Research Topics

Disease

159Neoplasms (Cancer)
12/2022 - 01/2005
39Carcinoma (Carcinomatosis)
03/2022 - 01/2006
22Neoplasm Metastasis (Metastasis)
05/2022 - 08/2006
19Renal Cell Carcinoma (Grawitz Tumor)
03/2022 - 01/2012
15Sarcoma (Soft Tissue Sarcoma)
10/2022 - 06/2014
11Melanoma (Melanoma, Malignant)
01/2021 - 09/2012
9Adenocarcinoma
03/2022 - 01/2006
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2018 - 08/2008
8Leiomyomatosis
01/2021 - 01/2013
7Infections
03/2022 - 08/2010
7Squamous Cell Carcinoma of Head and Neck
02/2021 - 09/2013
6Ewing Sarcoma (Sarcoma, Ewing)
11/2021 - 09/2016
6Margins of Excision
08/2021 - 02/2014
6Lymphatic Metastasis
05/2021 - 06/2011
6Immunoglobulin G4-Related Disease
11/2020 - 01/2011
6Inflammation (Inflammations)
01/2019 - 01/2011
5Salivary Gland Neoplasms (Salivary Gland Cancer)
05/2022 - 06/2012
5Disease Progression
05/2022 - 11/2014
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 12/2014
4Carcinogenesis
12/2022 - 02/2015
4Medullary Carcinoma
11/2021 - 07/2014
4Rhabdoid Tumor (Rhabdoid Tumors)
11/2021 - 11/2014
4Acinar Cell Carcinoma
02/2021 - 01/2019
4Fibrosis (Cirrhosis)
11/2020 - 01/2011
4Hemangiosarcoma (Angiosarcoma)
01/2017 - 04/2012
4Heart Failure
01/2014 - 01/2013
4Ulcerative Colitis
04/2013 - 08/2011
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2013
3Pleomorphic Adenoma
01/2022 - 09/2019
3Soft Tissue Neoplasms
01/2021 - 01/2016
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021 - 06/2017
3Lung Neoplasms (Lung Cancer)
01/2021 - 06/2014
3Perivascular Epithelioid Cell Neoplasms
01/2021 - 01/2011
3Leiomyoma (Uterine Fibroids)
11/2020 - 01/2013
3Hodgkin Disease (Hodgkin's Disease)
01/2020 - 01/2012
3Hyperplasia
01/2020 - 03/2006
3Stomach Neoplasms (Stomach Cancer)
11/2019 - 01/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 06/2014
3Meningioma (Meningiomas)
08/2016 - 01/2012
2Genetic Translocation (Chromosomal Translocation)
03/2022 - 01/2019
2Small Cell Carcinoma
01/2022 - 01/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 08/2021

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
12/2022 - 06/2012
13RNA (Ribonucleic Acid)IBA
10/2022 - 06/2014
13Keratins (Keratin)IBA
02/2022 - 01/2006
12Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
12Messenger RNA (mRNA)IBA
02/2021 - 01/2011
11Biological ProductsIBA
01/2022 - 01/2005
11DesminIBA
12/2020 - 03/2006
10Sucrose (Saccharose)IBA
01/2020 - 08/2015
9ParaffinIBA
08/2022 - 09/2013
9Fumarate Hydratase (Fumarase)IBA
01/2021 - 01/2016
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2007
8Phenobarbital (Luminal)FDA Link
12/2021 - 01/2006
7Transcription Factors (Transcription Factor)IBA
10/2022 - 04/2009
7SynaptophysinIBA
02/2022 - 12/2011
7VimentinIBA
02/2022 - 01/2005
6Capsules (Microcapsules)IBA
01/2022 - 08/2013
6LigandsIBA
01/2022 - 06/2016
6S100 Proteins (S 100 Protein)IBA
10/2019 - 06/2011
5Chromogranin AIBA
02/2022 - 12/2011
5AntigensIBA
01/2022 - 09/2012
5Circulating Tumor DNAIBA
11/2021 - 01/2019
5B7-H1 AntigenIBA
02/2021 - 11/2017
5AntibodiesIBA
04/2020 - 07/2012
5Immunoglobulin G (IgG)IBA
01/2020 - 01/2011
5SteroidsIBA
10/2019 - 05/2011
5Claudin-1IBA
04/2017 - 06/2011
4Formaldehyde (Formol)FDA Link
08/2022 - 06/2016
4trans-sodium crocetinate (crocetin)IBA
02/2022 - 11/2021
4MART-1 AntigenIBA
02/2022 - 01/2013
4Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 08/2014
4Anaplastic Lymphoma KinaseIBA
01/2021 - 06/2014
4Calmodulin-Binding Proteins (Caldesmon)IBA
12/2018 - 01/2009
4IpilimumabIBA
01/2018 - 06/2015
4Mucin-1 (CA 15-3 Antigen)IBA
07/2014 - 01/2005
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2022 - 01/2020
3Differentiation AntigensIBA
03/2022 - 01/2016
3Calbindin 2IBA
02/2022 - 05/2015
3Tumor Biomarkers (Tumor Markers)IBA
11/2021 - 09/2016
3ChromatinIBA
01/2021 - 01/2020
3Indicators and Reagents (Reagents)IBA
06/2018 - 01/2013
3Carrier Proteins (Binding Protein)IBA
08/2017 - 01/2012
3Death-Associated Protein KinasesIBA
11/2015 - 03/2013
3Imatinib Mesylate (Gleevec)FDA Link
04/2013 - 04/2011
2Genetic Markers (Genetic Marker)IBA
11/2021 - 12/2020
2Immune Checkpoint InhibitorsIBA
02/2021 - 01/2018
2Programmed Cell Death 1 ReceptorIBA
02/2021 - 01/2021

Therapy/Procedure

49Therapeutics
05/2022 - 08/2010
12Drug Therapy (Chemotherapy)
05/2022 - 07/2011
9Radiotherapy
05/2022 - 01/2015
6Chemoradiotherapy
03/2022 - 04/2016
5Lasers (Laser)
08/2021 - 01/2012
5Heart Transplantation (Grafting, Heart)
12/2020 - 01/2012
5Aftercare (After-Treatment)
08/2020 - 01/2012
4Neck Dissection (Radical Neck Dissection)
05/2021 - 02/2015
3Immunotherapy
01/2022 - 06/2015
3Neoadjuvant Therapy
10/2021 - 02/2014
3Palliative Care (Palliative Therapy)
01/2021 - 01/2013
2Combined Modality Therapy
10/2021 - 09/2014